Hypertension

28 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Cardiovascular Diseases

Narrower: Essential Hypertension 1

Treatments and conditions

Hypertension
Treatment and conditionWhere it standsTrials
Baxdrostat for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Bread with added beta-glucans for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CagriSema for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Clazakizumab for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Control for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Endocalyx Pro for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Exercise for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Exploratory test group for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fixed-Dose Combination Strategy for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High-resistance inspiratory muscle strength training for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
IBI3016 for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ime for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Inspiratory muscle strength training for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Inspiratory muscle training (IMT) for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Lorundrostat for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mandibular advancement Device for essential hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Mandibular advancement Device for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Orforglipron for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Placebo + Lorundrostat for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Placebo + Orforglipron for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QD for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
SAL0140 for hypertensionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tai Chi (CHI) for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Test group for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for hypertensionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vicadrostat for hypertensionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.